CHMG CHEMUNG FINANCIAL CORP
Permanent stock page ↗Financials · Russell 2000
Next earnings: Tue 26 Jan 2027 · estimated
What 7 analyst firms say about CHEMUNG FINANCIAL CORP: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
6 rated views · 8 analyst/firm records · 7 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8015
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8048
Recent analyst activity · last 90 days
Our tracked history has 13 reports on CHMG from 6 analyst firms in the last 90 days (7 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target and 1 has its first observed target in the past year.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: Raymond James raised its target from $87.00 (set 2 Sep 2026) to $90.00 on 27 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| DA Davidson | Jake Civiello | — | 26 Oct 2026 | 96.00 USD |
| Hovde Group | Feddie Strickland | Hold | 12 Oct 2026 | 88.00 USD |
| Keefe Bruyette & Woods | Christopher T O'Connell | Hold | 8 Jul 2026 | 81.00 USD |
| Keefe Bruyette & Woods | David Konrad | Hold | 28 Jul 2026 | 81.00 USD |
| Raymond James | Nicholas Holowko | Buy | 27 Oct 2026 | 90.00 USD |
| UBS | Unnamed analyst | Buy | 27 Oct 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 23 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Buy | 26 Oct 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:01 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.